Commonwealth Bank of Australia’s QIAGEN NV QGENF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-3,682
Closed -$103K 911
2016
Q4
$103K Sell
3,682
-415
-10% -$11.6K ﹤0.01% 633
2016
Q3
$113K Hold
4,097
﹤0.01% 616
2016
Q2
$89K Hold
4,097
﹤0.01% 635
2016
Q1
$91K Hold
4,097
﹤0.01% 647
2015
Q4
$112K Buy
4,097
+441
+12% +$12.1K ﹤0.01% 647
2015
Q3
$94K Buy
+3,656
New +$94K ﹤0.01% 664
2014
Q2
Sell
-206,186
Closed -$4.35M 1250
2014
Q1
$4.35M Hold
206,186
0.03% 477
2013
Q4
$4.91M Sell
206,186
-56,249
-21% -$1.34M 0.03% 422
2013
Q3
$5.62M Hold
262,435
0.04% 369
2013
Q2
$5.22M Buy
+262,435
New +$5.22M 0.04% 368

Other funds holding QGENF

Commonwealth Bank of Australia's QGENF Position: Q1 2017 in Review

Commonwealth Bank of Australia sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 3,682 shares — an estimated $103K sold.

Commonwealth Bank of Australia first reported a position in QGENF in Q2 2013 and held it in 10 quarters. The position peaked at $5.62M in Q3 2013. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Commonwealth Bank of Australia reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 3,682 QIAGEN NV shares in Q1 2017, an estimated $103K.
  • Commonwealth Bank of Australia first reported a position in QIAGEN NV in Q2 2013 and held it in 10 quarters.
  • Commonwealth Bank of Australia's QIAGEN NV position peaked at $5.62M in Q3 2013.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Commonwealth Bank of Australia's 13F filing for Q1 2017, filed 15 May 2017.